<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; lymph</title>
	<atom:link href="http://pharmaexecnews.com/tag/lymph/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmaexecnews.com</link>
	<description></description>
	<lastBuildDate>Wed, 08 Sep 2010 08:00:50 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Fastest Growing Therapeutic Classes (by Sales)</title>
		<link>http://pharmaexecnews.com/biotechnology/fastest-growing-therapeutic-classes-sales/</link>
		<comments>http://pharmaexecnews.com/biotechnology/fastest-growing-therapeutic-classes-sales/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 08:00:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Analgesics]]></category>
		<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Central Nervous System]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Companies]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Drug Trials]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Generics]]></category>
		<category><![CDATA[Government Policy]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Respiratory]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[adenoviruses]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biomolecules]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[Breast cancer]]></category>
		<category><![CDATA[c reactive protein]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[generic drugs]]></category>
		<category><![CDATA[lymph]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[micro technology]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Pharmacogenomics]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Proteomics]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10540</guid>
		<description><![CDATA[Oncologics, lipid regulators, respiratory agents, antidiabetics and anti-ulcerants are the five largest drug classes by sales. But annual sales are only half the story. Which drug classes are booming, and which have plateaued&#8211;or even dropped? IMS Health has released top-line industry data revealing the 15 largest drug classes, and we&#8217;ve crunched the numbers to take a closer [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/fastest-growing-therapeutic-classes-sales/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clinical Trial Participation Alone May Not Be Associated With Improved Outcomes for Childhood Cancer Patients</title>
		<link>http://pharmaexecnews.com/biotechnology/clinical-trial-participation-improved-outcomes-childhood-cancer-patients/</link>
		<comments>http://pharmaexecnews.com/biotechnology/clinical-trial-participation-improved-outcomes-childhood-cancer-patients/#comments</comments>
		<pubDate>Thu, 11 Mar 2010 08:00:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Drug Trials]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[lymph]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Pharmacogenomics]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10093</guid>
		<description><![CDATA[Children with the most common childhood cancer did not experience improved outcomes from participating in a clinical trial between 1997 and 2005.

Carl Koschmann, M.D., and colleagues at the University of Washington and Seattle Children&#8217;s Hospital studied 322 patients with newly diagnosed acute lymphoblastic leukemia (a cancer involving the white blood cells), approximately half of whom [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/clinical-trial-participation-improved-outcomes-childhood-cancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sound of Melanoma: Ultrasound Can Help Doctors Find Cancer More Accurately</title>
		<link>http://pharmaexecnews.com/pharmaceuticals/markets/sound-melanoma-ultrasound-doctors-find-cancer-accurately/</link>
		<comments>http://pharmaexecnews.com/pharmaceuticals/markets/sound-melanoma-ultrasound-doctors-find-cancer-accurately/#comments</comments>
		<pubDate>Thu, 25 Feb 2010 08:00:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Devices and Technology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medical Procedures]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[lymph]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10041</guid>
		<description><![CDATA[Knowing the stage of a patient&#8217;s melanoma is important when choosing the best course of treatment. When the cancer has progressed to the lymph nodes, a more aggressive treatment is needed. Examining an entire lymph node for cancer takes much effort and time. Now, a new technique might help make the process more efficient.

University of [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/pharmaceuticals/markets/sound-melanoma-ultrasound-doctors-find-cancer-accurately/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Symptoms of Lymphoma</title>
		<link>http://pharmaexecnews.com/biotechnology/biomedical/symptoms-lymphoma/</link>
		<comments>http://pharmaexecnews.com/biotechnology/biomedical/symptoms-lymphoma/#comments</comments>
		<pubDate>Fri, 22 May 2009 06:45:43 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Cancer - Non-Hodgkin Lymphoma]]></category>
		<category><![CDATA[lymph]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[non-hodgkin]]></category>
		<category><![CDATA[symptoms of lymphoma]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=504</guid>
		<description><![CDATA[As recently as 1950, lymphoma was almost inevitably fatal but these days up to 90 per cent of those newly diagnosed with Hodgkin&#8217;s lymphoma can expect to be cured. Non-Hodgkin&#8217;s is less easily treated, with an overall cure rate of about 60 per cent.

There may be no symptoms until the lymphoma has spread. Lymphoma can [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/biomedical/symptoms-lymphoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Failure of Treatment in Lymphoma</title>
		<link>http://pharmaexecnews.com/biotechnology/biomedical/failure-treatment-lymphoma/</link>
		<comments>http://pharmaexecnews.com/biotechnology/biomedical/failure-treatment-lymphoma/#comments</comments>
		<pubDate>Thu, 05 Mar 2009 18:16:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Blood and Lymphatic System - Dyslipidemia]]></category>
		<category><![CDATA[Hodgkin]]></category>
		<category><![CDATA[lymph]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[stages of lymphatic cancer]]></category>
		<category><![CDATA[treatment of lymphatic cancer]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=396</guid>
		<description><![CDATA[Lymphoma is a group of neoplasms that derive from immune cells residing in the lymph system. The nosology used to differentiate these neoplasms has evolved hand-in-hand with the evolution of the understanding of the immune system and its malignancies. The key distinctions between types of lymphoma are based on cell type and rate of growth. [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/biomedical/failure-treatment-lymphoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Facts to Know about Non Hodgkins Lymphoma</title>
		<link>http://pharmaexecnews.com/biotechnology/biomedical/facts-hodgkins-lymphoma/</link>
		<comments>http://pharmaexecnews.com/biotechnology/biomedical/facts-hodgkins-lymphoma/#comments</comments>
		<pubDate>Tue, 03 Mar 2009 18:05:46 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[blood]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancer - Non-Hodgkin Lymphoma]]></category>
		<category><![CDATA[epstein-barr virus]]></category>
		<category><![CDATA[lymph]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[non-hodgkin]]></category>
		<category><![CDATA[non-hodgkin’s lymphoma]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=394</guid>
		<description><![CDATA[Non-Hodgkin&#8217;s lymphoma is cancer that originates in your lymphatic system, the disease-fighting network spread throughout your body. In non-Hodgkin&#8217;s lymphoma, tumors develop from white blood cells (lymphocytes). These tumors can occur at different locations in your body. There are more than 30 types of non-Hodgkin&#8217;s lymphoma.

Non-Hodgkin&#8217;s lymphoma is more than seven times as common as [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/biomedical/facts-hodgkins-lymphoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>How To Determine The Stage Of Lymphoma</title>
		<link>http://pharmaexecnews.com/pharmaceuticals/determine-stage-lymphoma/</link>
		<comments>http://pharmaexecnews.com/pharmaceuticals/determine-stage-lymphoma/#comments</comments>
		<pubDate>Fri, 27 Feb 2009 17:28:41 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Blood and Lymphatic System – Hyperlipemia]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[hodgkins]]></category>
		<category><![CDATA[lymph]]></category>
		<category><![CDATA[lymph node]]></category>
		<category><![CDATA[lymphatic system]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[non-hodgkins lymphoma]]></category>
		<category><![CDATA[stages of lymphatic cancer]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=385</guid>
		<description><![CDATA[Lymphoma is a type of cancer involving cells of the immune system, called lymphocytes. Just as cancer represents many different diseases, lymphoma represents many different cancers of lymphocytes-about 35 different subtypes, in fact. Therefore, lymphoma is a group of cancers that affect the cells that play a role in the immune system, and primarily represents [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/pharmaceuticals/determine-stage-lymphoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
